Tech Company Financing Transactions
Pinnacle Biologics Funding Round
Pinnacle Biologics closed a funding round on 12/21/2012. Investors included NXT Capital.
Transaction Overview
Company Name
Announced On
12/21/2012
Transaction Type
Debt
Amount
Unknown
Round
Undisclosed
Investors
NXT Capital (Peter Fair)
Proceeds Purpose
NXT Capital's Venture Finance Group today announced that it has provided financing to support Pinnacle Biologics' acquisition of cancer-treating laser equipment. "The acquisition will allow Pinnacle to further pursue its efforts to utilize PDT to treat new and existing cancers and rare diseases."
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
311 South Wacker Dr. 4990
Chicago, IL 60606
USA
Chicago, IL 60606
USA
Phone
Website
Email Address
Overview
Pinnacle Biologics specializes in revitalizing healthcare therapies by promoting, developing and managing innovative approaches to the global commercialization of products in the oncology and specialty areas.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
President
Robert Altman
Browse more venture capital transactions:
Prev: 12/21/2012: ShopWell Solutions venture capital transaction
Next: 12/21/2012: BlueCava venture capital transaction
Share this article
About Our VC Transactions Data
We report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs